Micro Hospitals

Clinitech Laboratory Ltd.

CTLLAB

₹36.18

0% (0)

Market Cap

₹8 Cr.

P/E

20.85

Clinitech Laboratory Ltd.
Overview
Financials
Benchmarking
Shareholding
Hospitals

Clinitech Laboratory Ltd.

Clinitech Laboratory Ltd.
Overview
Financials
Benchmarking
Shareholding
Hospitals

Price
Growth Table
Balance Sheet
Profit & Loss
Cash Flow
Cash Flow Analysis
Ratios
Quarterly Results
Reverse DCF

FAQs on Clinitech Laboratory Ltd. Shareprice

Has the share price of Clinitech Laboratory grown faster than its competition?

There is not enough historical data for the companies share price.

Is Clinitech Laboratory stock expensive?

Clinitech Laboratory is not expensive.
Latest PE of Clinitech Laboratory is 20.85, while 3 year average PE is 42.33.
Also latest EV/EBITDA of Clinitech Laboratory is 0 while 3yr average is 18.29.

View FAQ's On Business

Growth Table

Clinitech Laboratory Ltd.
Dr Lalchandani Labs
Loading...
DhanvantriJeevan Rek
Loading...

In %	1yr	2yr	3yr	4yr	5yr	6yr	7yr	8yr	9yr	10yr
Share Price CAGR	—	—	—	—	—	—	—	—	—	—
TTM EPS CAGR	—	—	—	—	—	—	—	—	—	—
Sales CAGR	129	—	—	—	—	—	—	—	—	—
PAT Margin (Abs Growth)	-3.86	-2.23	-3.04	—	—	—	—	—	—	—
PE CAGR	—	—	—	—	—	—	—	—	—	—
CFO CAGR	-90.98	-65.70	-33.13	—	—	—	—	—	—	—

* Share price and PE growth are updated everyday. All other fields are as of latest financial year end. EPS adjusted for bonus and splits.

Balance Sheet

Clinitech Laboratory Ltd.
Dr Lalchandani Labs
Loading...
DhanvantriJeevan Rek
Loading...

In Rs. Cr.	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Assets	2.64	3.58	5.88	5.44	10.71
Non Current Assets	1.10	2.30	4.07	2.90	3.37
Net Block	0.84	1.65	1.33	1.71	2.12
Capital Work in Progress	0.08	0.41	0.56	0.94	—
Intangible Assets Under Development	—	0.41	0.56	—	1.01
Long Term Investments	0.09	0.14	2.02	0.07	0.07
Current Assets	1.63	1.38	1.96	2.71	7.34
Inventory	0.09	0.16	0.14	0.28	0.53
Accounts Receivable	0.56	0.36	0.49	0.60	1.54
Short Term Investments	—	—	—	—	—
Cash & Bank Balances	0.32	0.10	0.78	0.70	3.08
Liabilities	2.64	3.58	5.88	5.44	10.71
Shareholders Funds	1.39	1.85	2.38	3.55	8.83
Share Capital	0.67	1.50	1.50	1.68	2.28
Reserves	0.72	0.35	0.88	1.87	6.55
Non Current Liabilities	0.49	0.37	1.74	0.26	0.20
Secured Loans	0.48	0.36	0.28	0.23	—
Unsecured Loans	—	—	—	—	—
Current Liabilities	0.77	1.36	1.76	1.63	1.68
Accounts Payable	0.46	0.52	0.40	0.35	0.63
Short Term Loans	0.00	0.46	0.67	0.58	—

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

Increase
Decrease
Total

No data available.

*Data is as of latest FY end

Profit & Loss

Clinitech Laboratory Ltd.
Dr Lalchandani Labs
Loading...
DhanvantriJeevan Rek
Loading...

In Rs. Cr.	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Sales	4.55	6.38	6.35	6.40	8.23
Operating Expenses	3.73	5.32	4.98	5.40	7.40
Raw Material	0.94	1.51	1.15	1.25	1.56
Material Cost (%)	22.35	22.67	18.37	17.23	18.93
Employee Cost	0.92	1.38	1.55	1.92	2.86
Power & Fuel Cost	0.07	0.09	0.08	0.09	—
Operating Profit	0.83	1.07	1.36	1.00	0.83
Other Income	0.04	0.07	0.02	0.04	0.23
OPM (%)	18.20	16.73	21.48	15.64	10.12
Depreciation and Amortisation	0.25	0.38	0.45	0.44	0.45
Interest	0.08	0.06	0.07	0.09	0.06
Profit Before Tax	0.55	0.70	0.86	0.51	0.56
Tax	0.14	0.19	0.25	0.13	0.16
Net Profit	0.40	0.51	0.61	0.37	0.40
Number of shares(Crs)	—	—	—	—	—
Dividend Payout Ratio(%)	0.00	0.00	0.00	0.00	—

TTM Values as of Mar 2025

Cash Flow

Clinitech Laboratory Ltd.
Dr Lalchandani Labs
Loading...
DhanvantriJeevan Rek
Loading...

In Rs. Cr.	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash from Operating Activity	0.38	0.96	1.25	0.11	-0.88
Profit Before Tax	0.55	0.70	0.86	0.51	0.56
Adjustments	0.17	0.31	0.41	0.59	0.29
OCF Before Working Capital	0.71	1.01	1.27	1.09	0.85
Working Capital Changes	-0.18	0.15	0.28	-0.84	-1.57
Taxes Paid	-0.15	-0.21	-0.30	-0.14	-0.16
Cash from Investing Activity	0.54	-1.47	-0.65	-0.64	-0.73
Net Fixed Assets Purchased	-0.19	-1.51	-0.28	-1.21	-0.86
Fixed Assets Purchased	-0.19	-1.51	-0.28	-1.21	-1.17
Fixed Assets Sold	—	—	—	—	0.31
Investment Purchased	—	-0.05	-1.88	—	—
Investment Sold	0.59	—	—	1.95	—
Interest Recieved	0.04	0.07	0.02	0.04	0.13
Dividends Recieved	—	—	—	—	—
Subsidiary Investments	—	—	—	—	—
Cash from Financing Activity	-0.88	0.29	0.09	0.45	3.98
Proceeds From Shares	—	—	—	0.68	—
Net Long Term Borrowings	-0.55	-0.12	-0.07	-0.05	-0.29
Proceeds From Borrowings	—	—	—	—	—
Repayment From Borrowings	-0.55	-0.12	-0.07	-0.05	-0.29
Interest Paid	-0.08	-0.06	-0.06	-0.07	-0.04
Dividend Paid	—	—	—	—	—
Net Cash Flow	0.04	-0.22	0.68	-0.08	2.37
Opening Cash & Cash Equivalents	0.28	0.32	0.10	0.78	0.70
Effect of FX	—	—	—	—	—
Closing Cash & Cash Equivalents	0.32	0.10	0.78	0.70	3.08
Net Capex (est)	0.19	1.51	0.28	1.21	0.86
Free Cash Flow (est)	0.19	-0.56	0.97	-1.09	-1.74

Cash Flow Analysis

Increase
Decrease
Total

No data available.

Ratios

= Dominant Factor

Clinitech Laboratory Ltd.
Dr Lalchandani Labs
Loading...
DhanvantriJeevan Rek
Loading...

	Mar'21	Mar'22	Mar'23	Mar'24
Operational Ratios
Quick Ratio	2.01	0.90	1.04	1.49
Liquid Assets (Crs)	1.54	1.23	1.82	2.43
Current Liabilities (Crs)	0.77	1.36	1.76	1.63
Current Ratio	2.13	1.02	1.12	1.66
Current Assets (Crs)	1.63	1.38	1.96	2.71
Current Liabilities (Crs)	0.77	1.36	1.76	1.63
Interest Coverage Ratio	7.82	13.15	13.37	6.40
EBIT (Crs)	0.63	0.76	0.93	0.60
Interest Expenses (Crs)	0.08	0.06	0.07	0.09
Fixed Asset Turnover	1.86	1.81	1.74	1.43
Net Sales (Crs)	4.55	6.38	6.35	6.40
Fixed Assets (Crs)	2.45	3.52	3.65	4.47
Cash Conversion Cycle	-113	-89.98	-111	-80.20
Inventory Days	7.14	7.00	8.54	12.12
Days Receivable	44.75	26.37	24.53	30.99
Days Payable	165	123	144	123
Debt to Equity Ratio	0.39	0.48	0.43	0.24
Total Debt (Crs)	0.54	0.89	1.03	0.86
Shareholders Equity (Crs)	1.39	1.85	2.38	3.55
Free Cash Flow/Sales (%)	4.11	-8.74	15.24	-17.09
Free Cash Flow(est) (Crs)	0.19	-0.56	0.97	-1.09
Net Sales (Crs)	4.55	6.38	6.35	6.40
Profitability Ratios
Gross Margin (%)	77.65	77.33	81.63	82.77
Op Profit Margin (%)	18.20	16.73	21.48	15.64
Operating Profit (Crs)	0.87	1.14	1.38	1.04
Net Sales (Crs)	4.55	6.38	6.35	6.40
Net Profit Margin (%)	8.84	8.03	9.66	5.80
Net Profit (Crs)	0.40	0.51	0.61	0.37
Net Sales (Crs)	4.55	6.38	6.35	6.40
ROCE (%)	33.31	34.27	22.66	15.72
EBIT (Crs)	0.63	0.76	0.93	0.60
Capital Employed (Crs)	1.88	2.22	4.12	3.81
Return on Assets (%)	15.21	14.32	10.43	6.82
Net Profit (Crs)	0.40	0.51	0.61	0.37
Total Assets (Crs)	2.64	3.58	5.88	5.44
ROIC (%)	29.33	25.41	49.60	13.62
Op Profit after Taxes (Crs)	0.43	0.50	0.65	0.41
Invested Capital (Crs)	1.47	1.97	1.31	3.04
ROE (%)	28.94	27.74	25.75	10.46
Net Profit Margin (%)	8.84	8.03	9.66	5.80
Asset Turnover ratio	1.72	1.78	1.08	1.18
Equity Multiplier	1.90	1.94	2.47	1.53
Adjusted EPS	2.68	3.42	4.09	2.21
Valuation Ratios
P/E	0.00	0.00	0.00	0.00
Price to Book	0.00	0.00	0.00	0.00
EV/EBITDA	1.01	2.00	1.27	1.77
Dividend Yield (%)	—	—	—	—

Quarterly Results

Clinitech Laboratory Ltd.
Dr Lalchandani Labs
Loading...
DhanvantriJeevan Rek
Loading...

In Rs. Cr.	Sep'23	Mar'24	Sep'24	Mar'25
Net Sales	3.06	3.35	4.08	4.16
Operating Expenses	2.79	2.62	3.52	3.88
Increase/Decrease in Stock	0.00	0.00	0.00	0.00
Raw Material	0.58	0.52	0.81	0.75
Employee Cost	1.17	1.12	1.41	1.45
Selling and Distribution Expenses	0.00	0.00	0.00	0.00
Electricity, Power & Fuel Cost	0.00	0.00	0.00	0.00
Gen_AdminExpenses	0.00	0.00	0.00	0.00
Miscellaneous Expenses	0.00	0.00	0.00	0.00
Operating Profit	0.27	0.73	0.56	0.28
Other Income	0.02	0.01	0.05	0.17
Interest	0.04	0.06	0.04	0.02
PBDT	0.26	0.68	0.57	0.43
Depreciation and Amortization	0.19	0.25	0.31	0.14
Profit Before Tax	0.07	0.43	0.26	0.29
Tax	0.00	0.13	0.04	0.12
Profit After Tax	0.07	0.30	0.22	0.17
Exceptional Items	0.00	0.00	0.00	0.00
Net Profit	0.07	0.30	0.22	0.17
Quarterly Ratios
EPS	0.45	1.81	0.97	0.76
Operating Profit Margin	8.89	21.76	13.64	6.66
Net Profit Margin	2.19	9.09	5.45	4.16

Reverse DCF

Earnings

Discount Rate (%)

Terminal Multiple

5 YEAR

10 YEAR

20 YEAR

28.30%

Implied Growth Rate over a 5 year period*

9.00%

Implied Growth Rate over a 10 year period*

3.40%

Implied Growth Rate over a 20 year period*

*Implied Growth calculated using Newton-Raphson method.

Learn how to use Reverse DCF

FAQs on Clinitech Laboratory Ltd. Financials

How strong is Clinitech Laboratory balance sheet?

Balance sheet of Clinitech Laboratory is strong.
It shouldn't have solvency or liquidity issues.

Is the debt of Clinitech Laboratory increasing or decreasing?

The net debt of Clinitech Laboratory is decreasing.
Latest net debt of Clinitech Laboratory is -₹3.08 Crs as of Mar-25.
This is less than Mar-24 when it was ₹0.13 Crs.

Is the profitablity of Clinitech Laboratory improving?

The profit is oscillating.
The profit of Clinitech Laboratory is ₹0.37 Crs for Mar 2024, ₹0.61 Crs for Mar 2023 and ₹0.51 Crs for Mar 2022

Does Clinitech Laboratory pay decent dividends?

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Clinitech Laboratory latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

How has Clinitech Laboratory allocated its funds?

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Capital Work in Progress, Inventory, Accounts Receivable, Short Term Loans & Advances

View FAQ's On Shareholding

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Clinitech Laboratory Ltd.

Clinitech Laboratory Ltd.

Has the share price of Clinitech Laboratory grown faster than its competition?

Is Clinitech Laboratory stock expensive?

How strong is Clinitech Laboratory balance sheet?

Is the debt of Clinitech Laboratory increasing or decreasing?

Is the profitablity of Clinitech Laboratory improving?

Does Clinitech Laboratory pay decent dividends?

How has Clinitech Laboratory allocated its funds?

SIGN UP FOR FREE